several industrial players have shown active interest in the field for technological innovations and product launch. For instance, in February 2025, Dr. Ronnapee Chaichawarat (profession of International School of Engineering, Chulalongkorn University, Thailand) launched exoskeleton wheelchair, a robotic suit specifically designed to help people with disabilities sit, stand and walk. Owing to the ongoing innovations, and rising incidence of neurological conditions, we believe that wheelchair mou...

The integration of AI technology with advanced diagnostic solutions helps in early sepsis detection with higher accuracy rate. Recently, investigators at Johns Hopkins University developed a Targeted Real-Time Early Warning System (TREWS) that features machine learning and AI technology for sepsis detection. This system has been used for two years in five different hospitals. Moreover, this system was used to analyze over 9,800 retrospectively confirmed sepsis cases and demonstrated AI's transf...

Intraocular lens manufacturers are also aiming to develop next-generation IOLs that offer clearer vision and require minimal post-operative downtime for patients to return to their daily routines. For instance, in June 2025, Johnson & Johnson (US) launched TECHNIS Odyssey next-generation intraocular lens in Europe, Canada, and the Middle East to correct presbyopia. These consistent innovations indicate that the intraocular lens market will remain competitive and progressive during the forecast p...

Some of the notable specimen collection cards market growth drivers includes rising initiatives of prenatal and newborn screening to identify the potential risk of genetic diseases. Notably, the direct blood spot collection cards serve as a gold standard for newborn testing protocols as it maintains sample integrity during storage and transportation. Early detection allows for timely intervention and treatment, which can significantly improve health outcomes, prevent severe developmental delays,...

Companies like Philips Healthcare (Netherland), Honeywell (US) and PointClickCare (Canada) are increasing their initiatives to develop smart hardware and software solutions for personalized care. For instance, in January 2025, iWOW (Singapore), introduced two groundbreaking age-tech products, namely the BOP Monitor and BOP Presence at CES 2025. These products are a part of a comprehensive suite of IoT solutions aims to detect accidental fall and monitor the moment of senior at home to keep them...

The global non-viral drug delivery systems market, valued at USD 8.6 billion in 2025, is projected to reach USD 11.3 billion in 2026 and USD 20.4 billion by 2035, with a 6.8% CAGR during the forecast period 2026 to 2035. In September 2024, NanoSyrinx raised USD 13 million in a seed funding round, in order to advance its intracellular nanosyringe technology that is aimed to target biologics to the sites that are difficult to target within the cell. The market report presents an in-depth analysis...

Several market players are leveraging partnerships and collaborations to develop cost-effective and cutting-edge solutions for microbiome diagnostics. For instance, in February 2025, Leucine Ruch Bio (India) announced a strategic partnership with Precision Diagnosticos (Brazil) to expand BugSpeaks (Leucine Rich Bio’s flagship microbiome testing technology) to Brazilian market. Besides technology expansion, the industrial players also focus on initiating education programs to raise awareness ab...

The global medical device CRO market, valued at USD 20.4 billion in 2025, is projected to grow to USD 22.0 billion in 2026 and USD 43.6 billion by 2035, representing a CAGR of 7.9% during the forecast period 2026 to 2035. The demand for advanced medical devices has intensified the pressure on medical device companies to not only meet rigorous regulatory standards but also expand their product offerings.

The global cancer diagnostics market is currently worth around USD 156 billion and is expected to reach USD 319 billion by 2032. It is expected to grow at a CAGR of 9.3% till 2032. According to the American Cancer Society, by 2050, the number of cancer cases will be predicted to increase to 35 million based solely on projected population growth. Further, Studies have indicated that misdiagnosis or late diagnosis can severely impact survival rates, underscoring the critical need for reliable diag...

The global veterinary hematology analyzers market is valued at USD 1.03 billion in 2025 and is poised to reach USD 1.74 billion by 2035, expecting to grow at a CAGR of 5.4% during the forecast period. The market is expected to be driven by the rising demand for advanced diagnostics tools, such as veterinary hematology analyzers and handheld analyzers for diagnosing infectious diseases in animals. Driven by the ongoing demand, several market players are expected to strengthen their product portfo...

Majority of the industrial players, such as Abbott Laboratories, B. Braun and Johnson & Johnson are continually accelerating their efforts to develop single use medical kits and other supplies. In order to leverage competitive edge, several industrial players are undertaking strategic initiatives, such as latest product launch, collaborations, and partnerships.For instance, in October 2024, Verathon (subsidiary of Roper Industries) launched first Spectrum QC eco (single-use video laryngoscope) m...

The medical device labeling market, valued at USD 333 million in 2025, is projected to reach USD 365 million in 2026 and USD 509 million by 2030, with a CAGR of 8.6% during the forecast period 2026 to 2035. As of August, over 30 medical devices were approved by the US FDA alone, in 2019. However, it is worth highlighting that more than 10% of product recalls observed in this market are attributed to medical device labeling related issues. Therefore, owing to the expertise and infrastructure req...

Considering a broad scope of 4D printing in healthcare industry, several industrial players are shifting to technological innovation for manufacturing surgical robots that can perform variety of surgical tasks with higher precision, biomedical splints, implants and smart biomaterials. In July 2025, Frisco Public Library entered into partnership with Xinyl Xiao in order to launch its first public class on 4D printing program. Unlike conventional 3D printing, 4D printing helps to create structures...

With growing concern of genetic disorders and chronic conditions across the globe, the healthcare industry has necessitated the carrier screening of prenatal and newborn. Several government organizations and industrial players are focusing on strategic initiatives to enhance carrier screening of individuals to determine couples at greater risk of genetic conditions. For instance, KK Women’s and Children’s Hospital and Temasek Foundation conjointly launched Temasek Foundation PREDICT (Parenth...

The global pen injectors market size, valued at USD 43.85 billion in 2024, is projected to reach USD 47.22 billion in 2025 and USD 87.19 billion by 2035, representing a CAGR of 6.3% during the forecast period. North America holds the largest share (41%), notably, Asia-Pacific is expected to see the highest growth due to increasing chronic illness rates and expanding healthcare access.

The global targeted drug delivery device market size is projected to grow from $427 Million in 2026 to $2,153 Million by 2035, representing a CAGR of 19.7% during the forecast period. The new research study consists of industry trends, detailed market analysis, clinical trial analysis, likely drug candidates and market impact analysis, along with the market forecast and opportunity analysis. Currently, there are more than 1,000 cell and gene therapies under development, most of which are being d...

The smart implants market is estimated to grow from USD 5.23 billion in 2024 to reach USD 6.36 billion in 2025 and USD 30.34 billion by 2035, representing a higher CAGR of 16.9% during the forecast period. Notably, industrial players, such as Abbott, Medtronic, OrthoSensor, and VeraSense are at the forefront of technological innovations in this field.

The medical disposables market is estimated to grow from USD 530.20 billion in 2024 to reach USD 611.15 billion in 2025 and USD 1974.30 billion by 2035, representing a higher CAGR of 12.4% during the forecast period. Presently, sterilization supplies segment holds 13% of the medical disposables market share. Sterilization supplies are essential to sterilize medical equipment and instrument that are consistently used for patient treatment.

The global DNA test kits market, valued at USD 1.57 billion in 2024, is projected to reach USD 1.91 billion in 2025 and USD 9.20 billion by 2035, representing a CAGR of 17.0% during the forecast period. Given the ongoing demand, numerous industrial players are accelerating their strategic initiatives to develop advanced DNA test kits for faster analysis of mutations.

The global proton therapy systems market, valued at USD 1.49 billion in 2024, is projected to reach USD 1.66 billion in 2025 and USD 4.09 billion by 2035, representing a CAGR of 9.4% during the forecast period. Owing to the ongoing initiatives and expanding adoption of advanced therapies, it is expected that proton therapy systems market will continue to expand substantially during the forecast period.